Clinical
New NeuraLynx Website Launch
- Sep 06, 2023
After the acquisition of Neuralynx into FHC’s family of brands, we are launching a new Neuralynx website! This rebuilt web…
After working together for many years, our companies have merged. We produce complimentary products with virtually no overlap. FHC remains headquartered in Maine and Neuralynx continues to operate from Bozeman, MT.
Our products are used in various therapies such as deep brain stimulation, ablation, resection, and for movement disorders such as Parkinson’s Disease, Epilepsy, Dystonia, and Essential Tremor. To see how FHC products are used visit Medical University of South Carolina's Medical Video Center and watch them explain their process for treating a patient with essential tremor.
Clinical
After the acquisition of Neuralynx into FHC’s family of brands, we are launching a new Neuralynx website! This rebuilt web…